Remicade (Infliximab)
Remicade (infliximab) is a monoclonal antibody therapy developed by Janssen and approved by the U.S. Food and Drug Administration (FDA) to treat several inflammatory diseases including rheumatoid arthritis and Crohn’s disease. The treatment also can be used for sarcoidosis when patients do not respond to…